Philipp Stroebel
Overview
Explore the profile of Philipp Stroebel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
492
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ekstrom T, Rosok R, Abdelrahman A, Parassiadis C, Manjunath M, Dittrich M, et al.
Gut
. 2025 Jan;
PMID: 39884837
Background: Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer with a 5-year survival rate of 12%. It has two major molecular subtypes: classical and basal, regulated by the master...
2.
Knoll L, Hamm J, Stroebel P, Jovan T, Goetze R, Singh S, et al.
Neoplasia
. 2024 May;
53:101002.
PMID: 38744194
Background: Pancreatic ductal adenocarcinoma (PDAC) poorly responds to antineoplastic agents. Discrepancies between preclinical success and clinical failure of compounds has been a continuous challenge and major obstacle in PDAC research....
3.
Schmidt J, Kaulfuss S, Ott H, Gaubert M, Reintjes N, Bremmer F, et al.
Hum Genet
. 2024 Jan;
143(2):159-168.
PMID: 38265560
The fibroblast growth factor receptors comprise a family of related but individually distinct tyrosine kinase receptors. Within this family, FGFR2 is a key regulator in many biological processes, e.g., cell...
4.
Roden A, Judge M, den Bakker M, Fang W, Jain D, Marx A, et al.
Histopathology
. 2023 Sep;
83(6):967-980.
PMID: 37722860
Aims: Thymic epithelial tumours (TET), including thymomas and thymic carcinomas and thymic neuroendocrine neoplasms, are malignant neoplasms that can be associated with morbidity and mortality. Recently, an updated version of...
5.
Emons G, Auslander N, Jo P, Kitz J, Azizian A, Hu Y, et al.
Br J Cancer
. 2022 May;
127(4):766-775.
PMID: 35597871
Purpose: Preoperative (neoadjuvant) chemoradiotherapy (CRT) and total mesorectal excision is the standard treatment for rectal cancer patients (UICC stage II/III). Up to one-third of patients treated with CRT achieve a...
6.
Latif M, Schmidt G, Mercan S, Rahman R, Gibhardt C, Stejerean-Todoran I, et al.
Gut
. 2022 Apr;
71(12):2561-2573.
PMID: 35365570
Objectives: Non-alcoholic fatty liver disease (NAFLD) can persist in the stage of simple hepatic steatosis or progress to steatohepatitis (NASH) with an increased risk for cirrhosis and cancer. We examined...
7.
Schade S, Koenig U, Mekolli A, Gaedcke J, Neesse A, Reinecke J, et al.
Case Rep Gastroenterol
. 2022 Mar;
16(1):80-88.
PMID: 35350679
Gastric cancer (GC) represents one of the most fatal neoplasms in gastrointestinal oncology and affected patients can only hope for cure in limited disease. In a metastatic situation however, patients...
8.
Wilke A, Doebele C, Zindel A, Lee K, Rieke S, Ceribelli M, et al.
Blood
. 2021 Oct;
139(4):538-553.
PMID: 34624079
Burkitt lymphoma (BL) is an aggressive lymphoma type that is currently treated by intensive chemoimmunotherapy. Despite the favorable clinical outcome for most patients with BL, chemotherapy-related toxicity and disease relapse...
9.
Santos E, Silva A, Stroebel P, Marinho A, Willcox N, Goncalves G, et al.
Neurol Clin Pract
. 2019 Mar;
9(1):48-52.
PMID: 30859007
Purpose Of Review: Thymomas appear very rarely after extended thymectomy for early-onset myasthenia gravis (EOMG). We describe 2 such cases that highlight potential early warning signs. Recent Findings: In their...
10.
Koenig A, Krug S, Mueller D, Barth P, Koenig U, Scharf M, et al.
PLoS One
. 2017 Dec;
12(12):e0188876.
PMID: 29232390
Chromogranin A (CgA) is a well-established marker for diagnosis and follow up of patients with gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN). Recently, it has been shown that plasma levels of CgA correlate...